BamSEC and AlphaSense Join Forces
Learn More

Medicines Co

Formerly NASDAQ: MDCO
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 92 pages Agreement and Plan of Merger by and Among the Medicines Company, Novartis AG and Medusa Merger Corporation November 23, 2019
12/34/56
EX-2.1
from 8-K 120 pages Purchase and Sale Agreement Dated as of November 28, 2017 by and Between the Medicines Company and Melinta Therapeutics, Inc
12/34/56
EX-2.1
from 8-K 92 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. Purchase and Sale Agreement Dated as of May 9, 2016 by and Among the Medicines Company, Chiesi Farmaceutici S.P.A. and Chiesi USA, Inc., Solely for Purposes of Article VII
12/34/56
EX-2.1
from 8-K 97 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. Purchase and Sale Agreement by and Between the Medicines Company, Mallinckrodt Hospital Products, Inc., Mallinckrodt Group Sarl, and Mallinckrodt Pharmaceuticals Ireland Limited December 18, 2015
12/34/56
EX-2.3
from 10-K 7 pages Settlement and Amendment to Merger Agreement
12/34/56
EX-2.1
from 8-K 98 pages ================================================================= Agreement and Plan of Merger Among: The Medicines Company, a Delaware Corporation; Napa Acquisition Corp. a Delaware Corporation; Tenaxis Medical, Inc., a Delaware Corporation; and Fortis Advisors LLC as Securityholders’ Representative Dated as of April 21, 2014 ======================================================================
12/34/56
EX-2.1
from 8-K 106 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. Agreement and Plan of Merger by and Among the Medicines Company, Ravioli Acquisition Corp., Fortis Advisors LLC as the Representative and Rempex Pharmaceuticals, Inc. Dated as of December 3, 2013
12/34/56
EX-2.1
from 8-K 117 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. Share Purchase Agreement by and Among the Medicines Company, Profibrix B.V., the Equityholders of Profibrix B.V. (Named Herein) the Warrantors (Named Herein) the Option Holders (Named Herein) and Stichting Profibrix Sellers Representative, Solely in Its Capacity as Representative Dated as of June 4, 2013
12/34/56
EX-2.1
from 8-K 207 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. Master Transaction Agreement by and Between Bristol-Myers Squibb Company and the Medicines Company December 11, 2012
12/34/56
EX-2.1
from 8-K 102 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. Agreement and Plan of Merger by and Among the Medicines Company, Silver Surfer Acquisition Corp., Fortis Advisors LLC as the Representative and Incline Therapeutics, Inc. Dated as of December 11, 2012
12/34/56
EX-2.3
from 10-K 7 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks Denote Omissions. Amendment to Sale and Purchase Agreement
12/34/56
EX-2.1
from 8-K 115 pages Agreement and Plan of Merger by and Among the Medicines Company, Boxford Subsidiary Corporation and Targanta Therapeutics Corporation Dated as of January 12, 2009
12/34/56
EX-2.1
from SC TO-C 115 pages Agreement and Plan of Merger by and Among the Medicines Company, Boxford Subsidiary Corporation and Targanta Therapeutics Corporation Dated as of January 12, 2009
12/34/56
EX-2.1
from 8-K/A 46 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks Denote Omissions. Public Deed Wilmerhale Sale and Purchase Agreement Regarding the Sale and Purchase of All Shares in Curacyte Discovery Gesellschaft Mit Beschränkter Haftung Notarized by Dr. Patrick Wamister 1
12/34/56
EX-2
from SC 13G/A 1 page Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-2
from SC 13G/A 1 page Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56